Kailera Therapeutics, Inc Common Stock

Kailera Therapeutics, Inc Common Stock

Yahoo Finance • 8 days ago

Kardigan rises in Nasdaq debut after upsized $400 million IPO

June 18 (Reuters) - Kardigan's shares rose 1.6% in their Nasdaq debut on ‌Thursday, after the heart drug ‌developer raised $400 million in an upsized U.S. initial ​public offering. The Princeton, New Jersey-based company's shares opened a... Full story

Yahoo Finance • 12 days ago

Notable healthcare headlines for the week: GSK, Parabilis Medicines, and Novo Nordisk in focus

Wall Street traded higher on Friday as investors focused on the highly anticipated public debut of SpaceX, with enthusiasm surrounding the offering helping support gains across major U.S. equity indexes. The blue-chip Dow Jones Industrial... Full story

Yahoo Finance • last month

Is Kailera Therapeutics a Buy After Its Sizzling IPO?

In the biotech sector, private companies are moving from the sidelines into the spotlight through initial public offerings (IPOs). One of the most recent is Kailera Therapeutics(NASDAQ: KLRA), a potential competitor to Eli Lilly and Novo N... Full story

Yahoo Finance • last month

This Weight-Loss Drug Challenger Could Follow Eli Lilly's Playbook: Analyst

On Tuesday, William Blair initiated coverage on Kailera Therapeutics Inc.(NASDAQ:KLRA), the latest entrant in the fast-growing weight-loss drug market. The obesity-focused biotech raised more than $600 million in April through an initial... Full story

Yahoo Finance • last month

Meet The New IPO Trying To Take On Eli Lilly And Novo Nordisk In Obesity

Analysts initiated covered Tuesday of IPO stock Kailera Therapeutics, a potential competitor to Lilly and Novo in obesity treatment. Continue Reading... Full story

Yahoo Finance • 2 months ago

Kailera IPO And Governance Overhaul Set Terms For NASDAQ Composite Debut

Never miss an important update on your stock portfolio and cut through the noise. Over 7 million investors trust Simply Wall St to stay informed where it matters for FREE. Kailera Therapeutics (NasdaqGS:KLRA) completed its initial public... Full story

Yahoo Finance • 2 months ago

A Kailera Therapeutics (KLRA) Insider Scooped up an Additional 500,000 Shares for $8.0 Million

On April 20, 2026, RTW Investments, a 10% Owner of Kailera Therapeutics(NASDAQ:KLRA), reported the acquisition of 500,000 shares of common stock at $16.00 per share, according to the SEC Form 4 filing. The firm also received 10.28 million... Full story